{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:23:52Z","timestamp":1776270232185,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":163,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Centre for Human Drug Research"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.bbi.2020.04.033","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T10:51:23Z","timestamp":1587034283000},"page":"515-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Challenging the challenge: A randomized controlled trial evaluating the inflammatory response and pain perception of healthy volunteers after single-dose LPS administration, as a potential model for inflammatory pain in early-phase drug development"],"prefix":"10.1016","volume":"88","author":[{"given":"H.J.","family":"Hijma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ziagkos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.","family":"de Kam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Moerland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.J.","family":"Groeneveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2020.04.033_b0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fcimb.2013.00045","article-title":"PGE(2) suppression of innate immunity during mucosal bacterial infection","volume":"3","author":"Agard","year":"2013","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"3","key":"10.1016\/j.bbi.2020.04.033_b0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.pain.2008.09.027","article-title":"Experimental muscle pain impairs descending inhibition","volume":"140","author":"Arendt-Nielsen","year":"2008","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.bbi.2020.04.033_b0015","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.pain.2011.12.001","article-title":"Acute experimental endotoxemia induces visceral hypersensitivity and altered pain evaluation in healthy humans","volume":"153","author":"Benson","year":"2012","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.bbi.2020.04.033_b0020","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/j.1476-5381.2011.01445.x","article-title":"The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice","volume":"165","author":"Booker","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2020.04.033_b0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/bja\/aen103","article-title":"Assessment of pain","volume":"101","author":"Breivik","year":"2008","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.bbi.2020.04.033_b0030","doi-asserted-by":"crossref","unstructured":"Brierley, S., Hughes, P., Harrington, A., Blackshaw, L.A., 2012. Innervation of the gastrointestinal tract by spinal and vagal afferent nerves. In: Physiology of the Gastrointestinal Tract, fifth ed., 2012.","DOI":"10.1016\/B978-0-12-382026-6.00024-5"},{"issue":"3","key":"10.1016\/j.bbi.2020.04.033_b0035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pneurobio.2009.04.003","article-title":"Stress-induced analgesia","volume":"88","author":"Butler","year":"2009","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.bbi.2020.04.033_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090013","article-title":"Lipopolysaccharide induces inflammatory hyperalgesia triggering a TLR4\/MyD88-dependent cytokine cascade in the mice paw","volume":"9","author":"Calil","year":"2014","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.bbi.2020.04.033_b0045","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jpain.2008.03.010","article-title":"Ethnic differences in diffuse noxious inhibitory controls","volume":"9","author":"Campbell","year":"2008","journal-title":"J. Pain."},{"issue":"5","key":"10.1016\/j.bbi.2020.04.033_b0050","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/ALN.0000000000001340","article-title":"Preclinical pain research: can we do better?","volume":"125","author":"Clark","year":"2016","journal-title":"Anesthesiology"},{"issue":"12","key":"10.1016\/j.bbi.2020.04.033_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084159","article-title":"Systemic inflammation decreases pain threshold in humans in vivo","volume":"8","author":"de Goeij","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbi.2020.04.033_b0060","doi-asserted-by":"crossref","unstructured":"De Jongh, R.F., Vissers, K.C., Meert, T.F., Booij, L.H., De Deyne, C.S., Heylen, R.J., 2003. The role of interleukin-6 in nociception and pain. Anesth. Analg. 96(4), 1096\u20131103, table of contents.","DOI":"10.1213\/01.ANE.0000055362.56604.78"},{"issue":"1","key":"10.1016\/j.bbi.2020.04.033_b0065","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/hmg\/ddi013","article-title":"Genetic basis for individual variations in pain perception and the development of a chronic pain condition","volume":"14","author":"Diatchenko","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbi.2020.04.033_b0070","article-title":"Characterization of inflammation and immune cell modulation induced by low-dose LPS administration to healthy volunteers","volume":"11","author":"Dillingh","year":"2014","journal-title":"J. Inflamm.-Lond."},{"issue":"3","key":"10.1016\/j.bbi.2020.04.033_b0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.spen.2016.10.003","article-title":"Pathogenesis of pain","volume":"23","author":"Dinakar","year":"2016","journal-title":"Semin. Pediatr. Neurol."},{"issue":"11","key":"10.1016\/j.bbi.2020.04.033_b0080","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1473-3099(05)70270-X","article-title":"Understanding the symptoms of the common cold and influenza","volume":"5","author":"Eccles","year":"2005","journal-title":"Lancet Infect. Dis."},{"issue":"40","key":"10.1016\/j.bbi.2020.04.033_b0085","doi-asserted-by":"crossref","first-page":"15952","DOI":"10.1523\/JNEUROSCI.1609-13.2013","article-title":"Blockade of Toll-like receptor 4 attenuates morphine tolerance and facilitates the pain relieving properties of morphine","volume":"33","author":"Eidson","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2020.04.033_b0090","doi-asserted-by":"crossref","first-page":"d12","DOI":"10.2741\/A171","article-title":"Cytokines in acute and chronic inflammation","volume":"2","author":"Feghali","year":"1997","journal-title":"Front. Biosci."},{"issue":"1","key":"10.1016\/j.bbi.2020.04.033_b0095","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1476-5381.1989.tb16860.x","article-title":"Inhibition by neuropeptides of interleukin-1 beta-induced, prostaglandin-independent hyperalgesia","volume":"98","author":"Follenfant","year":"1989","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbi.2020.04.033_b0100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.mehy.2005.03.010","article-title":"Persistence of inflammatory cytokines cause a spectrum of chronic progressive diseases: implications for therapy","volume":"65","author":"Forrester","year":"2005","journal-title":"Med. Hypotheses."},{"issue":"7147","key":"10.1016\/j.bbi.2020.04.033_b0105","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/nature05836","article-title":"Gene-specific control of inflammation by TLR-induced chromatin modifications","volume":"447","author":"Foster","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbi.2020.04.033_b0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3233\/NIB-2012-012041","article-title":"Inflammatory hyperalgesia: the role of the prostaglandin system in the spinal cord","volume":"3","author":"Fujikawa","year":"2012","journal-title":"Adv. Neuroimmune. Biol."},{"issue":"24","key":"10.1016\/j.bbi.2020.04.033_b0115","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1002\/sim.2072","article-title":"Efficiency of the cross-over design: an empirical estimation","volume":"23","author":"Garcia","year":"2004","journal-title":"Stat. Med."},{"issue":"12","key":"10.1016\/j.bbi.2020.04.033_b0120","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2522\/ptj.20130597","article-title":"Chronic stress, cortisol dysfunction, and pain: a psychoneuroendocrine rationale for stress management in pain rehabilitation","volume":"94","author":"Hannibal","year":"2014","journal-title":"Phys. Ther."},{"key":"10.1016\/j.bbi.2020.04.033_b0125","article-title":"Determining pain detection and tolerance thresholds using an integrated, multi-modal pain task battery","volume":"110","author":"Hay","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bbi.2020.04.033_b0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bbi.2013.03.002","article-title":"Low-dose endotoxin potentiates capsaicin-induced pain in man: evidence for a pain neuroimmune connection","volume":"30","author":"Hutchinson","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"7","key":"10.1016\/j.bbi.2020.04.033_b0135","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/1753425916663638","article-title":"Pain perception in healthy volunteers: effect of repeated exposure to experimental systemic inflammation","volume":"22","author":"Janum","year":"2016","journal-title":"Innate. Immun."},{"issue":"2","key":"10.1016\/j.bbi.2020.04.033_b0140","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0022-510X(94)90036-1","article-title":"Diffuse noxious inhibitory control. Reappraisal by pain-related somatosensory evoked potentials following CO2 laser stimulation","volume":"125","author":"Kakigi","year":"1994","journal-title":"J. Neurol. Sci."},{"issue":"2\u20133","key":"10.1016\/j.bbi.2020.04.033_b0145","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0304-3959(96)03068-0","article-title":"Endotoxin-induced local inflammation and hyperalgesia in rats and mice: a new model for inflammatory pain","volume":"66","author":"Kanaan","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.bbi.2020.04.033_b0150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbi.2014.11.014","article-title":"Modality and sex differences in pain sensitivity during human endotoxemia","volume":"46","author":"Karshikoff","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"Suppl 1","key":"10.1016\/j.bbi.2020.04.033_b0155","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/S0889-1591(02)00077-6","article-title":"Cytokine-induced sickness behavior","volume":"17","author":"Kelley","year":"2003","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2020.04.033_b0160","doi-asserted-by":"crossref","first-page":"40149","DOI":"10.1038\/srep40149","article-title":"Characterization of a model of systemic inflammation in humans in vivo elicited by continuous infusion of endotoxin","volume":"7","author":"Kiers","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbi.2020.04.033_b0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2010-08-265892","article-title":"Cytokine release from innate immune cells: association with diverse membrane trafficking pathways","volume":"118","author":"Lacy","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bbi.2020.04.033_b0170","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/bcp.13448","article-title":"Demonstration of an anti-hyperalgesic effect of a novel pan-Trk inhibitor PF-06273340 in a battery of human evoked pain models","volume":"84","author":"Loudon","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbi.2020.04.033_b0175","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/cpt.522","article-title":"Evidence of NI-0101 pharmacological activity, an anti-TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS","volume":"101","author":"Monnet","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.bbi.2020.04.033_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186964","article-title":"Prolonged immune alteration following resolution of acute inflammation in humans","volume":"12","author":"Motwani","year":"2017","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.bbi.2020.04.033_b0185","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/jpet.109.164806","article-title":"Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase","volume":"334","author":"Naidu","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"12","key":"10.1016\/j.bbi.2020.04.033_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122777","article-title":"Lipopolysaccharide-induced acute kidney injury is dependent on an IL-18 receptor signaling pathway","volume":"18","author":"Nozaki","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bbi.2020.04.033_b0195","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/bcp.13183","article-title":"The use of a battery of pain models to detect analgesic properties of compounds: a two-part four-way crossover study","volume":"83","author":"Okkerse","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbi.2020.04.033_b0200","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.pain.2013.01.003","article-title":"Characterisation and mechanisms of bradykinin-evoked pain in man using iontophoresis","volume":"154","author":"Paterson","year":"2013","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.bbi.2020.04.033_b0205","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1476-5381.1992.tb14361.x","article-title":"Peripheral analgesic activities of peptides related to alpha-melanocyte stimulating hormone and interleukin-1 beta 193\u2013195","volume":"106","author":"Poole","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbi.2020.04.033_b0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cbi.2015.05.007","article-title":"Vinpocetine reduces lipopolysaccharide-induced inflammatory pain and neutrophil recruitment in mice by targeting oxidative stress, cytokines and NF-kappaB","volume":"237","author":"Ruiz-Miyazawa","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.bbi.2020.04.033_b0215","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1742-7843.2006.pto_211.x","article-title":"Multi-modal and tissue-differentiated experimental pain assessment: reproducibility of a new concept for assessment of analgesics","volume":"98","author":"Staahl","year":"2006","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"5","key":"10.1016\/j.bbi.2020.04.033_b0220","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1056\/NEJM198908033210503","article-title":"The cardiovascular response of normal humans to the administration of endotoxin","volume":"321","author":"Suffredini","year":"1989","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bbi.2020.04.033_b0225","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/ejp.1217","article-title":"Fear of pain and cortisol reactivity predict the strength of stress-induced hypoalgesia","volume":"22","author":"Timmers","year":"2018","journal-title":"Eur. J. Pain."},{"issue":"3","key":"10.1016\/j.bbi.2020.04.033_b0230","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejpain.2005.03.010","article-title":"Time dependent differences in pain sensitivity during unilateral ischemic pain provocation in healthy volunteers","volume":"10","author":"Tuveson","year":"2006","journal-title":"Eur. J. Pain."},{"issue":"7","key":"10.1016\/j.bbi.2020.04.033_b0235","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ejp.1222","article-title":"Effect profile of paracetamol, Delta9-THC and promethazine using an evoked pain test battery in healthy subjects","volume":"22","author":"van Amerongen","year":"2018","journal-title":"Eur. J. Pain."},{"key":"10.1016\/j.bbi.2020.04.033_b0240","doi-asserted-by":"crossref","unstructured":"van der Heijden, C.D.C.C., Noz, M.P., Joosten, L.A.B., Netea, M.G., Riksen, N.P., Keating, S.T., 2017. Epigenetics and Trained Immunity. Antioxid Redox Sign.","DOI":"10.1089\/ars.2017.7310"},{"key":"10.1016\/j.bbi.2020.04.033_b0245","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biochi.2018.06.014","article-title":"Experimental human endotoxemia as a model of systemic inflammation","volume":"159","author":"van Lier","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.bbi.2020.04.033_b0250","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.vascn.2017.10.004","article-title":"Characterization of immune cell, endothelial, and renal responses upon experimental human endotoxemia","volume":"89","author":"van Poelgeest","year":"2018","journal-title":"J. Pharmacol. Toxicol. Methods."},{"issue":"4","key":"10.1016\/j.bbi.2020.04.033_b0255","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000480424","article-title":"Endotoxin effects on cardiac and renal functions and cardiorenal syndromes","volume":"44","author":"Virzi","year":"2017","journal-title":"Blood Purif."},{"key":"10.1016\/j.bbi.2020.04.033_b0260","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbi.2014.05.001","article-title":"Inflammation-induced hyperalgesia: effects of timing, dosage, and negative affect on somatic pain sensitivity in human experimental endotoxemia","volume":"41","author":"Wegner","year":"2014","journal-title":"Brain Behav. Immun."},{"issue":"10","key":"10.1016\/j.bbi.2020.04.033_b0265","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1097\/j.pain.0000000000000256","article-title":"Inflammation-induced pain sensitization in men and women: does sex matter in experimental endotoxemia?","volume":"156","author":"Wegner","year":"2015","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.bbi.2020.04.033_b0270","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.coph.2010.05.009","article-title":"The translatability of animal models for clinical development: biomarkers and disease models","volume":"10","author":"Wendler","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbi.2020.04.033_b0275","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1111\/bph.13469","article-title":"Diacylglycerol lipase beta inhibition reverses nociceptive behaviour in mouse models of inflammatory and neuropathic pain","volume":"173","author":"Wilkerson","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbi.2020.04.033_b0280","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1124\/jpet.117.243808","article-title":"Investigation of diacylglycerol lipase alpha inhibition in the mouse lipopolysaccharide inflammatory pain model","volume":"363","author":"Wilkerson","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.bbi.2020.04.033_b0285","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7150\/ijms.7.251","article-title":"Intrathecal siRNA against Toll-like receptor 4 reduces nociception in a rat model of neuropathic pain","volume":"7","author":"Wu","year":"2010","journal-title":"Int. J. Med. Sci."},{"issue":"6","key":"10.1016\/j.bbi.2020.04.033_b0290","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/ejp.605","article-title":"Recommendations on practice of conditioned pain modulation (CPM) testing","volume":"19","author":"Yarnitsky","year":"2015","journal-title":"Eur. J. Pain."},{"issue":"11","key":"10.1016\/j.bbi.2020.04.033_b0295","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/nrd.2017.202","article-title":"Breaking barriers to novel analgesic drug development","volume":"16","author":"Yekkirala","year":"2017","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"2","key":"10.1016\/j.bbi.2020.04.033_b0300","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation, and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int. Anesthesiol. Clin."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159119316186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159119316186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:04:04Z","timestamp":1760169844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159119316186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":60,"alternative-id":["S0889159119316186"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2020.04.033","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenging the challenge: A randomized controlled trial evaluating the inflammatory response and pain perception of healthy volunteers after single-dose LPS administration, as a potential model for inflammatory pain in early-phase drug development","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2020.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}